Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Vitamin D
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
'''Vitamin D''' is a fat-soluble steroid [[hormone]] responsible for the intestinal absorption of [[calcium]], [[iron]], [[magnesium]], [[Phosphorus|phosphate]] and [[zinc]]. In humans, dietary Vitamin D is negligible; most comes from exposure of skin to sunlight or from supplementation. ==Function == Vitamin D is fat-soluble, regulates calcium levels, helps modulate the immune system, and is vital to good bone health.<ref name="vdr" /><ref name="Paul2011" /> === Vitamin D2 === Vitamin D2, known as ergocalciferol, is a vitamin D found in plants, mushrooms, and yeasts, and sometimes in foods fortified with vitamin D.<ref name="lpi">{{Cite web|url=https://lpi.oregonstate.edu/mic/vitamins/vitamin-D | title = Vitamin D | date = 2014-04-22 | website = Linus Pauling Institute|language=en|access-date=2018-12-23}}</ref> === Vitamin D3 === Vitamin D3, known as cholecalciferol, is synthesized in the human skin from the UVB radiation in sunlight. D3 can also be obtained from [[:Category:Supplements|supplements]].<ref name="lpi" /> ==VDR gene == The VDR gene, also known as nuclear receptor subfamily 1 group I member 1, provides instructions for making vitamin D receptor, which controls the body's response to vitamin D.<ref name="vdr">https://medlineplus.gov/genetics/gene/vdr/</ref> Vitamin D-dependent rickets, alopecia areata (an autoimmune disease), intervertebral disc disease, kidney stones and leprosy have all been linked to the VDR gene.<ref name="vdr" /> == Immune function == Vitamin D improves [[regulatory T cell]] function in healthy adults<ref name="bock2011">{{Cite journal | doi = 10.1002/dmrr.1276| issn = 1520-7560| volume = 27 | issue = 8| pages = 942–945| last1 = Bock | first1 = Gerlies | last2 = Prietl | first2 = Barbara | last3 = Mader | first3 = Julia K. | last4 = Höller | first4 = Evelyne | last5 = Wolf | first5 = Michael | last6 = Pilz | first6 = Stefan | last7 = Graninger | first7 = Winfried B. | last8 = Obermayer-Pietsch | first8 = Barbara M. | last9 = Pieber | first9 = Thomas R.| title = The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial| journal = Diabetes/Metabolism Research and Reviews| date = Nov 2011 | pmid = 22069289 | url = https://pubmed.ncbi.nlm.nih.gov/22069289 }}</ref> <ref name="smolders2009">{{Cite journal | doi = 10.1371/journal.pone.0006635| issn = 1932-6203| volume = 4 | issue = 8| pages = 6635| last1 = Smolders | first1 = Joost | last2 = Thewissen | first2 = Mariëlle | last3 = Peelen | first3 = Evelyn | last4 = Menheere | first4 = Paul | last5 = Tervaert | first5 = Jan Willem Cohen | last6 = Damoiseaux | first6 = Jan | last7 = Hupperts | first7 = Raymond| title = Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis| journal = PLOS ONE| access-date = 2016-11-10| date = 2009-08-13| url = http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006635}}</ref> and in patients with relapsing remitting [[multiple sclerosis]],<ref name="smolders2009" /> suggesting that it may play a role in both preventing and ameliorating [[autoimmune disease]]. Experimental studies have shown that vitamin D helps protect against a proliferation of [[CD4+ T cell]]s, and reduces the number of [[Th1]] and [[interleukin 17|IL-17]] cytokines.<ref name="Paul2011">https://www.atsjournals.org/doi/full/10.1164/rccm.201108-1502CI</ref> == Infectious disease == Vitamin D deficiency increases the risk of viral infections.{{Citation needed}} ===Epstein-Barr virus=== An [[Epstein-Barr virus]] protein [[EBNA]]-3 has an affinity for the [[Vitamin D receptor]] and may actually block the activation of VDR-dependent genes by Vitamin D.<ref name="hellman2010">{{Cite journal| doi = 10.1007/s00018-010-0441-4| issn = 1420-9071| volume = 67 | issue = 24| pages = 4249–4256| last1 = Yenamandra | first1 = Surya Pavan | last2 = Hellman | first2 = Ulf | last3 = Kempkes | first3 = Bettina | last4 = Darekar | first4 = Suhas Deoram | last5 = Petermann | first5 = Sabine | last6 = Sculley | first6 = Tom | last7 = Klein | first7 = George | last8 = Kashuba | first8 = Elena | title = Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes| journal = Cellular and molecular life sciences: CMLS| date = Dec 2010 | pmid = 20593215 | url = https://doi.org/10.1007%2Fs00018-010-0441-4 }}</ref> ==Deficiency == Vitamin D deficiency can cause complex medical problems, and because vitamin D cannot be absorbed from sunlight shining through windows, people who are [[severe and very severe ME|mostly or totally housebound]] are particularly at risk of Vitamin D deficiency.{{citation needed | date = 2022}} {{See also|Vitamin D deficiency}} ==Supplementation== ===Recommended level=== The recommended blood level of Vitamin D varies considerably by government body and health society. The US [[Institute of Medicine]] suggests levels between 20 ng/ml and 50ng/ml.<ref name="mayovitd">{{cite web | last = Theimer | first= Sharon | date = 2015-03-15 | title = Vitamin D Toxicity Rare in People Who Take Supplements, Mayo Clinic Study Finds|url= http://newsnetwork.mayoclinic.org/discussion/vitamin-d-toxicity-rare-in-people-who-take-supplements-mayo-clinic-study-finds/| publisher= Mayo Clinic News Network|access-date= 2016-11-10}}</ref> The Vitamin D Council suggests a level of 50 ng/ml or 125 nmol/l as ideal.<ref name="VitDcouncil">[https://www.vitamindcouncil.org/about-vitamin-d/testing-for-vitamin-d/ Vitamin D Council - Testing for vitamin D]</ref><ref name="Why50nmgl">[https://www.vitamindcouncil.org/blog/why-should-you-keep-your-vitamin-d-level-around-50-ngml/ Vitamin D Council - Why should you keep your vitamin D level around 50 ng/ml?]</ref> In the [[United States]], 41.6% have serum levels below 20 ng/ml, the threshold for deficiency or 82.1% of African-Americans and 69.2% of Hispanics.<ref name="forrest2011">{{Cite journal| doi = 10.1016/j.nutres.2010.12.001| issn = 1879-0739| volume = 31 | issue = 1| pages = 48–54| last1 = Forrest | first1 = Kimberly Y. Z. | last2 = Stuhldreher | first2 = Wendy L.| title = Prevalence and correlates of vitamin D deficiency in US adults| journal = Nutrition Research (New York, N.Y.)| date = Jan 2011 | pmid = 21310306 | url = https://tahomaclinic.com/Private/Articles4/WellMan/Forrest%202011%20-%20Prevalence%20and%20correlates%20of%20vitamin%20D%20deficiency%20in%20US%20adults.pdf }}</ref> ===Toxicity=== Taking very high Vitamin D levels long term can cause [[hypercalcemia]], which causes serious health problems, although more serious effects like kidney stones are relatively rare. Taking very high amounts of [[calcium]] (1,000mg daily) combined with moderate levels of vitamin D can also be harmful. The NHS and the US Office of Dietary Supplements both recommend a maximum daily limit of 100mcg (4,000IU).<ref name="mayovitd" /> == ME/CFS == A retrospective study found patients with CFS have lower levels of Vitamin D than the general population. However, it was uncertain whether this is correlated with the amount of time CFS patients spend indoors or with some other factor.<ref name="berkovitz2013">{{Cite journal | doi = 10.1024/0300-9831.79.4.250| issn = 0300-9831| volume = 79 | issue = 4| pages = 250–254| last1 = Berkovitz | first1 = Saul | authorlink = Saul Berkovitz | last2 = Ambler | first2 = Gareth | last3 = Jenkins | first3 = Michael | last4 = Thurgood | first4 = Sue| title = Serum 25-hydroxy Vitamin D Levels in Chronic Fatigue Syndrome: a Retrospective Survey| journal = International Journal for Vitamin and Nutrition Research| date = 2009-07-01| url = http://econtent.hogrefe.com/doi/abs/10.1024/0300-9831.79.4.250}}</ref><ref name="abokrysha2012">{{Cite journal | doi = 10.1111/j.1526-4637.2011.01304.x| issn = 1526-4637| volume = 13 | issue = 3| pages = 452–458| last = Abokrysha | first = Noha T.| title = Vitamin D deficiency in women with fibromyalgia in Saudi Arabia| journal = Pain Medicine (Malden, Mass.)| date = March 2012 | pmid = 22221390 | url = https://academic.oup.com/painmedicine/article/13/3/452/1852088}}</ref> Raising Vitamin D levels has reportedly resulted in remission for some CFS patients.<ref name="IACFSME">[https://iacfsme.org/PDFS/Attachment-E-Annedore-Hoeck,-Vitamin-D.aspx IACFS/ME - Vitamin D deficiency results in chronic fatigue and multi-system symptoms]</ref> Recent research has found no toxicity at 10,000 IU per day and levels as high as 15,000 IU/day are probably tolerated.{{citation needed | date = 2022}} At this dosage it will take 75-90 before symptom improvement is expected to be seen. Some people have seen some symptoms improved within days, but those are likely a small minority.{{Citation needed}} In 2015, Witham et al. found that high-dose oral vitamin D3 did not improve markers of vascular health or fatigue in patients with [[chronic fatigue syndrome]]. The study consisted of patients meeting the the [[Fukuda criteria]] (1994) for CFS and the [[Canadian Consensus Criteria|Canadian (2003) ME/CFS criteria]] who were either given 100,000 units oral vitamin D3 or a matching placebo every 2 months for 6 months.<ref name="Witham2015" /> In 2017, a study by Earl et al. concluded that low serum concentrations of total 25(OH)D do not appear to be a contributing factor to the level of fatigue of CFS/ME.<ref name="Earl2017">[https://doi.org/10.11136/bmjopen-2016-015296 Earl KE, Sakellariou GK, Sinclair M, et al. Vitamin D status in chronic fatigue syndrome/myalgic encephalomyelitis: a cohort study from the North-West of England. BMJ Open. 2017;7(11):e015296. doi:10.1136/bmjopen-2016-015296]</ref> == Fibromyalgia == A cohort of Saudi women with [[fibromyalgia]] was found to be Vitamin D deficient. Vitamin D status was inversely correlated with [[pain]]. High dose Vitamin D supplementation resulted in improvement or resolution of symptoms.<ref name="abokrysha2012" /> A second study also found improvement of symptoms with Vitamin D supplementation.<ref name="matthana2011">{{Cite journal | issn = 0379-5284| volume = 32 | issue = 9| pages = 925–929| last = Matthana | first = Mona H.| title = The relation between vitamin D deficiency and fibromyalgia syndrome in women| journal = Saudi Medical Journal| date = Sep 2011 | pmid = 21894355 | url = https://pubmed.ncbi.nlm.nih.gov/21894355/ }}</ref> == Autoimmune disease == Low vitamin D is a possible or known risk factor for [[systemic lupus erythematosus]],<ref name="kamen2006">{{Cite journal | doi = 10.1016/j.autrev.2005.05.009| issn = 1568-9972| volume = 5 | issue = 2| pages = 114–117| last1 = Kamen | first1 = Diane L. | last2 = Cooper | first2 = Glinda S. | last3 = Bouali | first3 = Henda | last4 = Shaftman | first4 = Stephanie R. | last5 = Hollis | first5 = Bruce W. | last6 = Gilkeson | first6 = Gary S.| title = Vitamin D deficiency in systemic lupus erythematosus| journal = Autoimmunity Reviews| series = Special Issue on CIS Spring School of Autoimmune Diseases| access-date = 2016-11-10| date = February 2006| url = http://www.sciencedirect.com/science/article/pii/S1568997205000935}}</ref> [[multiple sclerosis]], [[rheumatoid arthritis]], type 1 diabetes,<ref name="Paul2011" /> [[inflammatory bowel disease]],<ref name="cantorna2004">{{Cite journal | issn = 1535-3702| volume = 229 | issue = 11| pages = 1136–1142| last1 = Cantorna | first1 = Margherita T. | last2 = Mahon | first2 = Brett D. | title = Mounting Evidence for Vitamin D as an Environmental Factor Affecting Autoimmune Disease Prevalence| journal = Experimental Biology and Medicine | date = 2004-12-01| url = http://ebm.sagepub.com/content/229/11/1136 | pmid = 15564440}}</ref> alopecia areata (an autoimmune disease causing hair to fall out),<ref name="vdr" /> and the autoimmune thyroid disease [[Hashimoto's thyroiditis (hypothyroidism)]].<ref name="bizzaro2015">{{Cite journal | doi = 10.1007/s12026-014-8579-z| issn = 1559-0755| volume = 61 | issue = 1-2| pages = 46–52| last1 = Bizzaro | first1 = Giorgia | last2 = Shoenfeld | first2 = Yehuda | title = Vitamin D and autoimmune thyroid diseases: facts and unresolved questions| journal = Immunologic Research| date = February 2015 | pmid = 25407646 | url = https://pubmed.ncbi.nlm.nih.gov/25407646/}}</ref> Active [[Crohn's disease]] has also been found to be associated with lower Vitamin D levels.<ref name="hvas2013">{{Cite journal| doi = 10.1016/j.crohns.2013.01.012| issn = 1876-4479| volume = 7 | issue = 10| pages = 407-413| last1 = Jørgensen | first1 = Søren Peter | last2 = Hvas | first2 = Christian Lodberg | last3 = Agnholt | first3 = Jørgen | last4 = Christensen | first4 = Lisbet Ambrosius | last5 = Heickendorff | first5 = Lene | last6 = Dahlerup | first6 = Jens Frederik| title = Active Crohn's disease is associated with low vitamin D levels| journal = Journal of Crohn's & Colitis| date = November 2013 | pmid = 23403039 | url = https://academic.oup.com/ecco-jcc/article/7/10/e407/379813}}</ref> ===Multiple sclerosis=== Among people with early stage [[multiple sclerosis]] (MS), those with higher vitamin D levels had better outcomes five years after follow up.<ref name="NIHvitd">{{Citation | last = Torgan | first = Carol | date = 2014-02-03 | title = Vitamin D Levels Predict Multiple Sclerosis Progression|url= http://www.nih.gov/news-events/nih-research-matters/vitamin-d-levels-predict-multiple-sclerosis-progression|newspaper= NIH Research Matters|access-date= 2016-11-10}}</ref><ref name="ms-trust-vitaminD" /> It is theorized that there may be a link between low Vitamin D, [[Epstein-Barr virus]] and MS.<ref name="holmoy2008">{{Cite journal| doi = 10.1016/j.mehy.2007.04.030| issn = 0306-9877| volume = 70 | issue = 1| pages = 66–69| last = Holmøy | first = Trygve| title = Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis| journal = Medical Hypotheses| access-date = 2016-11-10| date = 2008| url = http://www.sciencedirect.com/science/article/pii/S0306987707003167}}</ref> <ref name="ms-trust-vitaminD">{{Cite web|url=https://mstrust.org.uk/life-ms/diet/vitamin-d | title = Vitamin D|website=MS Trust|language=en|access-date=2021-03-11}}</ref><ref name="ms-trust-ebv">{{Cite web|url=https://mstrust.org.uk/a-z/epstein-barr-virus | title = Epstein Barr virus|website=MS Trust|language=en|access-date=2021-03-11}}</ref> There are high levels of both vitamin D deficiency among Scotland's 15,000 MS sufferers;<ref name="ms-scotland">{{Cite web|url=https://www.mssociety.org.uk/contact-us/scotland | title = Scotland | last = | first = | author-link =| date = |website=Multiple Sclerosis Society UK|language=en|archive-url=|archive-date=|url-status=|access-date=2021-03-11}}</ref> Scotland has the highest prevalence of MS anywhere in the world at over 200 per 100,000 of the population, with over 400 per 100,000 in Orkney, and Scottish ancestry is a recognized risk factor.<ref name="Tarlington2019">{{Cite journal | last = Tarlinton | first = Rachael Eugenie|author-link = | last2 = Khaibullin | first2=Timur | author-link2 = | last3 = Granatov | first3 = Evgenii | author-link3 = | last4 = Martynova | first4 = Ekaterina | authorlink4 = | last5 = Rizvanov | first5 = Albert | authorlink5 = |last6 = Khaiboullina | first6 = Svetlana | authorlink6 = | date = Jan 2019 | title = The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis|url=https://www.mdpi.com/1422-0067/20/2/303|journal=International Journal of Molecular Sciences|language=en|volume=20|issue=2|pages=303|doi=10.3390/ijms20020303|pmc=|pmid=|access-date=|quote=|via=}}</ref><ref name="ms-trust">{{Cite web|url=https://mstrust.org.uk/a-z/prevalence-and-incidence-multiple-sclerosis | title = Prevalence and incidence of multiple sclerosis|website=MS Trust|language=en|access-date=2021-03-11}}</ref> ==Notable studies== *2014, Association between vitamin D status and markers of vascular health in patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)<ref name="Witham2014">{{Cite journal | last1 = Witham | first1 = Miles | authorlink1 = | last2 = Kennedy | first2 = Gwen | authorlink2 = | last3 = Belch | first3 = Jill | authorlink3 = | last4 = Hill | first4 = Alexander | authorlink4 = | last5 = Khan | first5 = Faisel | authorlink5 = Faisel Khan | title = Association between vitamin D status and markers of vascular health in patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) | journal = International Journal of Cardiology | volume = 174 | issue = 1 | page = 139 - 140 | date = 2014 | pmid = 25455721 | url = https://www.researchgate.net/profile/Jill-Belch/publication/261292125_Association_between_vitamin_D_status_and_markers_of_vascular_health_in_patients_with_chronic_fatigue_syndromemyalgic_encephalomyelitis_CFSME/links/5e1ddc32a6fdcc28e9c70319/Association-between-vitamin-D-status-and-markers-of-vascular-health-in-patients-with-chronic-fatigue-syndrome-myalgic-encephalomyelitis-CFS-ME.pdf | doi = 10.1016/j.ijcard.2014.03.145}}</ref> *2015, Effect of intermittent vitamin D3 on vascular function and symptoms in chronic fatigue syndrome – A randomised controlled trial<ref name="Witham2015">{{Cite journal | last1 = Witham | first1 = MD | authorlink1 = | last2 = Adams | first2 = F | authorlink2 = | last3 = McSwiggan | first3 = S | authorlink3 = | last4 = Kennedy | first4 = G | authorlink4 = | last5 = Kabir | first5 = G | authorlink5 = | last6 = Belch | first6 = JJ | authorlink6 = | last7 = Khan | first7 = F | authorlink7 = Faisel Khan | title = Effect of intermittent vitamin D3 on vascular function and symptoms in chronic fatigue syndrome – A randomised controlled trial | journal = Nutrition, Metabolism and Cardiovascular Diseases | volume = 25 | issue = 3 | page = 287-294 | date = 2015 | url = https://www.nmcd-journal.com/article/S0939-4753(14)00315-9/fulltext | pmid = 25455721 | doi =10.1016/j.numecd.2014.10.007}}</ref> *2017, Vitamin D status in chronic fatigue syndrome/myalgic encephalomyelitis: a cohort study from the North-West of England <ref name="Earl2017" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695299/ (Full Text)] *2018, Exogenous VD3 alleviates chronic fatigue syndrome by activating MEKs/ERKs-SIRT1 signaling pathway in skeletal muscle<ref name="Wu2018">{{Cite journal | last =Wu | first = Fangnan | last2 = Huder | first2=Chaolu | last3 = Tian | first3=Zhenjun | date = 2018-10-04 | title = PO-132 Exogenous VD3 alleviates chronic fatigue syndrome by activating MEKs/ERKs-SIRT1 signaling pathway in skeletal muscle|url=https://ojs.uclouvain.be/index.php/EBR/article/view/10353|journal=Exercise Biochemistry Review|language=en|volume=1|issue=4|doi=10.14428/ebr.v1i4.10353|issn=2593-7588}}</ref> [https://ojs.uclouvain.be/index.php/EBR/article/view/10353 (Abstract)] ==See also== *[[Vitamin D deficiency]] *[[Photophobia]] (light sensitivity) *[[Severe and very severe ME]] *[[Dr Lapp's supplement recommendations]] *[[Malnutrition]] ==Learn more== *[http://lpi.oregonstate.edu/mic/vitamins/vitamin-D Linus Pauling Institute Micronutrient Information Center - Vitamin D] *[https://www.drugs.com/vitamin-d.html Vitamin D] - drugs.com *[https://medlineplus.gov/ency/article/002405.htm Vitamin D] - MedlinePlus Encyclopedia ==References == {{reflist}} [[Category:Potential treatments]] [[Category:Supplements]] [[Category:Vitamins]] [[Category:Nutrients]]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Templates used on this page:
MediaWiki:Colon-separator/en
(
view source
)
MediaWiki:Seealso/en
(
view source
)
Template:Category handler
(
edit
)
Template:Citation
(
edit
)
Template:Citation needed
(
edit
)
Template:Cite journal
(
edit
)
Template:Cite web
(
edit
)
Template:Colon
(
edit
)
Template:Digits
(
edit
)
Template:Fix
(
edit
)
Template:Fix/category
(
view source
) (protected)
Template:Full stop
(
edit
)
Template:GetFallback
(
edit
)
Template:LangSwitch
(
edit
)
Template:Last word
(
edit
)
Template:Main other
(
edit
)
Template:Reflist
(
edit
)
Template:See also
(
edit
)
Template:Str len
(
edit
)
Template:Uselang
(
edit
)
Template:Year
(
edit
)
Module:Arguments
(
edit
)
Module:Category handler
(
edit
)
Module:Category handler/blacklist
(
edit
)
Module:Category handler/config
(
edit
)
Module:Category handler/data
(
edit
)
Module:Category handler/shared
(
edit
)
Module:Check for unknown parameters
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:Namespace detect/config
(
edit
)
Module:Namespace detect/data
(
edit
)
Module:No globals
(
edit
)
Module:String
(
edit
)
Module:Unsubst
(
edit
)
Module:Yesno
(
edit
)
This page is a member of 3 hidden categories:
Category:All articles with unsourced statements
Category:Articles with unsourced statements from 2022
Category:Articles with unsourced statements from unknown year
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs